081203; News- Yale is scared shipless

[Mort Zuckerman]

To: emcsw...@nasw.org, zerh...@od.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, the-...@nytimes.com, biz...@nytimes.com,
for...@nytimes.com, me...@nytimes.com, nati...@nytimes.com,
dv...@cdc.gov, brigidc...@optonline.net, tr...@hotmail.com,
illino...@aol.com, jle...@courant.com, tinaj...@yahoo.com,
jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, FalN...@aol.com,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@po.state.ct.us,
randall...@usdoj.gov, robert....@yale.edu
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org

Subject: News- Yale is scared shipless

Date: Dec 3, 2008 5:38 AM

Check it out. "Advocates without scientific training, blah, blah,
blah..."

Well, the fact is, I am the only scientist in the Lyme arena
(I wrote the original ILADS.org Klempner rebuttal, which apparently,
ILADS.org did not even understand since they've never in 7 years
been able to independently recite the arguments), and any class
action
against Yale would consist of only 2 witnesses: Someone from the
FDA's Bioanalytics Division and Yale's Erol Fikrig, because the rules
for bioanalytical detection were met in 1991, with Yale's Flagellin
method, which was patented in 1993.

The evidence that IDSA/Yale/ALDF refused to turn over to the CT
Attorney General is not included in the so-called literature
cited below, but you can find it all on my website, and Mr.
Blumenthal's staff was given this data, too (twice- the first
batch was stolen off the CT Attorney General's desk by DCF's
Jessica Gauvin, which is clearly a FELONY:
http://www.actionlyme.org/andersonpenisbiter.htm
http://www.actionlyme.org/PENISBITERDOCS.htm

Yale is not going to win this hit-back. The whole scientific
world outside of America knows what has gone on here, because
I can tell from my site statistics that universities and
governments of foreign nations are all over my website
every day.

Yale does not want to be sued in a class action, and neither
does the State of CT, but Yale has put CT in that position,
since they OWN the CT Medical Board. That is, the CT Medical
Board is loaded with Yale physicians, but Yale physicians'
malpractice is not ever investigated by the Medical Board,
which is CT *POLICY.*

THENCE, both Yale and the State of CT can be sued in a class
action. Or, I could sue them both myself because of the
criminal actions of Yale's James Phillips and AAG Jessica
Gauvin.

Did I not get charged with being a Unabomber Chemist?

Has anyone ever gotten a mail-bomb from me?

Who is *CRAZY* around here?


The Qui Tam award will be bigger, however, than anything
I get from the State or Yale, since I am the whistleblower
for both crimes: What Steere did in Europe (I am a former
analytical methods development and VALIDATION chemist for Pfizer)
with the funky strains, and the Pam3Cys or LYMErix immune
suppression outcomes:
http://www.actionlyme.org/PAM3CYS_IMMUNE_SUPPRESSION.htm

It is MDs who are brainless and they all know it.

They're all Kool-Aid drinkers.

There is no way out of prosecution for the Yale/Steere
perps, including duh DCF, Lenny Sigal, Eddie McSweegan
and Durland Fish.


Their crimes are clear; all in black and white.

All I need is the two witnesses- who I can subpoena and they
will *have* to come. Fikrig and Flavell's names are on both
patents- LYMErix and the Flagellin method. They also wrote the
reports which show LYMErix failed *and* did not "disinfect ticks,"
as SmithKline and Yale falsely claimed, as the latter was your
basic BOGUS ARTICLE:
http://www.actionlyme.org/SELF_INDICTING_PERPS_FIKRIG.htm

Using immunofluorescing antibodies to look for antigens that are
not expected to be there due to selection pressure, spirochetes
being washed away, and not a DNA or RNA method to determine
whether or not sucking on a LYMErix-vaccinated disinfected
ticks when Yale had *OWNED* a Bb-specific DNA sequence for
Bb specific flagellin?


ROTFLMAO.

Ha, ha, ha. I never heard of anything so silly in my life.

Ya really gotta be a first-class nitwit to even try it.


Kathleen M. Dickson
http://www.actionlyme.org
http://www.relapsingfever.org

====================================================
http://www.yaledailynews.com/articles/view/26785

King: Watch out for Lyme disease

* Print
* Email
* Write Editor
* Share
o Digg
o Facebook
o Newsvine
o Reddit

Leslie P. King
Health Harbingers
Published Wednesday, December 3, 2008
Your Name
Your Email
Friend's Name
Friend's Email
Message
Submit
Close

Lyme disease, dubbed one of the “deadly dozen” by a recent Wildlife
Conservation
Society report, could skyrocket as global shifts in temperature and
precipitation
transform ecosystems. Vector-borne diseases such as Lyme are
transmitted to humans
by insects, and they, like the insects that act as the vectors, tend
to be specific
to a distinct ecosystem. But climate change may lead to a loss of
these natural
boundaries — generating a spike in rates of Lyme and other infectious
diseases.

The incidence and migration of Lyme disease throughout the upper East
Coast and
Midwest should be a warning to us. The restoration of the deciduous
forests to the
eastern United States after their near-total destruction by European
immigrants
was a crowning achievement of the Conservationist Movement. The new
habitat is mostly
devoid of large predators, as a result of hunting and other human
activities, allowing
many large mammals to flourish unfettered. Since Lyme disease is
transferred to
humans by the bite of the adult deer tick, the prevalence of Lyme
disease is correlated
with the population of deer. Connecticut is grossly overpopulated with
deer, having
approximately 60 deer per square mile in a habitat that can
sustainably support
no more than 10. These are the ideal conditions for the propagation of
the disease.
(Indeed, Connecticut is the epicenter of Lyme disease. The
Constitution State already
has the nation’s highest Lyme disease prevalence, and it is rising.)

Lyme disease has been associated with controversy since 1977, when
then-Yale physician
Dr. Allen Steere reclassified a group of misdiagnosed cases of
juvenile arthritis
as Lyme arthritis. Dr. Steere named the newly discovered disease
process for the
location of the patient cluster: Lyme, in southwestern Connecticut.
The most recent
dispute involves the diagnosis of chronic Lyme disease or post Lyme
syndrome. Most
scientists and researchers vehemently deny the existence of chronic
Lyme disease,
citing numerous studies that demonstrate no biological evidence for
its existence.
Patient advocacy groups dispute the scientific evidence and often
enjoy outsized
influence over policymakers.

The recent skirmishes surrounding the diagnosis of chronic Lyme
disease are a remarkable
instance of déjà vu. GlaxoSmithKline’s 1998 LYMErix vaccine was
created to address
the rising Lyme disease epidemic. Vaccine recipients, often supported
by patient
advocacy groups, filed class-action lawsuits against GlaxoSmithKline,
alleging LYMErix
caused health problems; as a result, LYMErix vaccine production ceased
in 2002.

Contemporary medical literature described the fate of LYMErix as “a
cautionary tale.”
Ten years later, the toxic environment surrounding Lyme disease and
the LYMErix
vaccine makes new significant scientific discourse virtually
impossible, as advocates
without the appropriate scientific training continue to dominate the
discussion.

Lyme disease is indeed a cautionary tale. Scientists must modify their
practice
of publishing solely for scholarly journals by also communicating
their findings
to a larger audience. Scientific expertise can contest patient
advocacy groups and
silence policymakers by demonstrating that these groups aren’t always
cognizant
of best treatment practices. Given the potential climate-driven
ecological changes
that could lead to the further increase of a widespread infection, the
noxious scientific
environment surrounding Lyme disease could become a perfect storm that
fuels a significant
epidemic.

Leslie King, M.D., M.P.H., is the founding director of Flying
Physicians International.
She currently is completing a one-year mid-career master’s degree at
the Yale School
of Forestry & Environmental Studies, focusing on communications

of the impacts of climate change on human health.